NCT07043465View on ClinicalTrials.gov

Ambulant Monitoring to Detect Hemodynamic and Electrical Impact of Severe Tricuspid Valve Regurgitation

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

October 31, 2024

Study Completion Date

December 31, 2024

Conditions

Tricuspid Regurgitation (TR)

Interventions

DIAGNOSTIC_TEST

14 days ambulatory rhythm monitoring

14 days ambulatory rhythm monitoring using Byteflies

Trial Locations (1)

3000

UZ Leuven, Leuven

All Listed Sponsors

lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT07043465 - Ambulant Monitoring to Detect Hemodynamic and Electrical Impact of Severe Tricuspid Valve Regurgitation | Biotech Hunter | Biotech Hunter